Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-05-08

FDA Approved: MIRTAZAPINE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for mirtazapine by Aurobindo Pharma Limited under ANDA077376.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • mirtazapine (mirtazapine)

Snippet

SUPPL AP for MIRTAZAPINE (MIRTAZAPINE)